• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒在药物递送中的毒理学

Toxicology of Nanoparticles in Drug Delivery.

作者信息

Sharma Swati, Parveen Roza, Chatterji Biswa Prasun

机构信息

St. Xavier's College, Mumbai, Maharashtra 400001 India.

School of Engineering, Ajeenkya DY Patil University, Pune, Maharashtra 412105 India.

出版信息

Curr Pathobiol Rep. 2021;9(4):133-144. doi: 10.1007/s40139-021-00227-z. Epub 2021 Nov 24.

DOI:10.1007/s40139-021-00227-z
PMID:34840918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8611175/
Abstract

Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges.

摘要

纳米颗粒已经彻底改变了生物医学,尤其是在药物递送领域,这得益于它们诸如系统稳定性、溶解度水平和靶位点特异性等引人关注的特性。然而,根据其在不同环境中的特性,纳米颗粒可能既有益又有害,因此凸显了在用于人体之前进行纳米毒理学研究的重要性。不同类型的纳米颗粒已被用于药物递送,本综述总结了这些纳米颗粒最近的毒性研究。本文详细讨论了在药物递送中广泛使用的三种纳米颗粒(金属、脂质和蛋白质纳米颗粒)的毒理学评估。研究记录了各种纳米颗粒的几种毒性作用,例如金属基纳米颗粒与氧化应激增加有关,并且有可能渗透到细胞核,而蛋白质基纳米颗粒的不良反应已被观察到具有肝毒性和肾毒性。鉴于纳米颗粒在药物递送中的应用日益增加,以及监管当局对纳米载体在生物体中的毒性日益关注,迫切需要关注识别毒性研究中的差距。该综述突出了毒性研究中的差距以及克服现有挑战的潜在重点领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f287/8611175/37a792a2a172/40139_2021_227_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f287/8611175/30c290d5525a/40139_2021_227_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f287/8611175/37a792a2a172/40139_2021_227_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f287/8611175/30c290d5525a/40139_2021_227_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f287/8611175/37a792a2a172/40139_2021_227_Fig2_HTML.jpg

相似文献

1
Toxicology of Nanoparticles in Drug Delivery.纳米颗粒在药物递送中的毒理学
Curr Pathobiol Rep. 2021;9(4):133-144. doi: 10.1007/s40139-021-00227-z. Epub 2021 Nov 24.
2
Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.用于口服递送大分子药物的纳米载体的毒性评估。
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):206-17. doi: 10.1016/j.ejpb.2015.10.005. Epub 2015 Oct 19.
3
Toxicological study of metal and metal oxide nanoparticles in zebrafish.金属和金属氧化物纳米颗粒在斑马鱼中的毒理学研究。
J Appl Toxicol. 2020 Jan;40(1):37-63. doi: 10.1002/jat.3910. Epub 2019 Dec 29.
4
Precision Nanotoxicology in Drug Development: Current Trends and Challenges in Safety and Toxicity Implications of Customized Multifunctional Nanocarriers for Drug-Delivery Applications.药物研发中的精准纳米毒理学:定制多功能纳米载体用于药物递送应用的安全性和毒性影响的当前趋势与挑战
Pharmaceutics. 2022 Nov 15;14(11):2463. doi: 10.3390/pharmaceutics14112463.
5
Toxicological perspectives of inhaled therapeutics and nanoparticles.吸入疗法和纳米颗粒的毒理学观点。
Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):933-47. doi: 10.1517/17425255.2014.916276. Epub 2014 May 8.
6
Green synthesis of silver nanoparticles: an approach to overcome toxicity.绿色合成银纳米粒子:克服毒性的一种方法。
Environ Toxicol Pharmacol. 2013 Nov;36(3):807-12. doi: 10.1016/j.etap.2013.07.005. Epub 2013 Jul 20.
7
Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: treatment strategies and anticipated applications of nanoparticles in gene delivery.工程纳米粒子在哺乳动物生殖细胞和发育胚胎中的潜在毒性:纳米粒子在基因传递中的治疗策略和预期应用。
Hum Reprod Update. 2016 Sep;22(5):588-619. doi: 10.1093/humupd/dmw020. Epub 2016 Jul 6.
8
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.用于递药应用的无机纳米颗粒的亚慢性和慢性毒性评价。
Adv Drug Deliv Rev. 2019 Apr;144:112-132. doi: 10.1016/j.addr.2019.07.006. Epub 2019 Jul 8.
9
Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.口服纳米颗粒作为药物载体的安全性和毒性问题。
Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):381-93. doi: 10.1517/17425255.2015.992781. Epub 2014 Dec 13.
10
Toxicological status of nanoparticles: What we know and what we don't know.纳米颗粒的毒理学状况:我们已知和未知的情况。
Chem Biol Interact. 2018 Nov 1;295:1-12. doi: 10.1016/j.cbi.2018.07.015. Epub 2018 Jul 23.

引用本文的文献

1
Molecular mechanisms and therapeutic strategies of GPX4 regulation in acute kidney injury.急性肾损伤中GPX4调控的分子机制与治疗策略
Pharmacol Rep. 2025 Aug 28. doi: 10.1007/s43440-025-00777-8.
2
Unlocking the potential of microalgae-derived therapeutic carriers: Characteristics, types, and nanomedical applications.释放微藻衍生治疗载体的潜力:特性、类型及纳米医学应用
Mater Today Bio. 2025 Jul 3;33:102037. doi: 10.1016/j.mtbio.2025.102037. eCollection 2025 Aug.
3
Toxicity Challenges and Current Advancement in Metal-Organic Frameworks (MOFs) for Biomedical Applications.

本文引用的文献

1
Grand Challenges in Nano-Based Drug Delivery.基于纳米技术的药物递送面临的重大挑战。
Front Med Technol. 2019 Dec 3;1:1. doi: 10.3389/fmedt.2019.00001. eCollection 2019.
2
Human Serum Albumin as Multifunctional Nanocarrier for Cancer Therapy.人血清白蛋白作为多功能纳米载体用于癌症治疗。
J Pharm Sci. 2021 Sep;110(9):3111-3117. doi: 10.1016/j.xphs.2021.05.001. Epub 2021 May 11.
3
When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications.当白蛋白遇上脂质体:一种适用于生物医学应用的可行药物载体。
用于生物医学应用的金属有机框架材料(MOFs)的毒性挑战与当前进展
Biol Trace Elem Res. 2025 Jun 24. doi: 10.1007/s12011-025-04712-z.
4
The Nanocarrier Landscape─Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective.纳米载体全景——评估关键药物递送载体及其性能:转化视角
ACS Appl Mater Interfaces. 2025 Jul 2;17(26):37383-37403. doi: 10.1021/acsami.5c07366. Epub 2025 Jun 17.
5
A comprehensive review of using nanomaterials in cancer immunotherapy: Pros and Cons of clinical usage.纳米材料在癌症免疫治疗中的应用综述:临床应用的利弊
3 Biotech. 2025 Jul;15(7):205. doi: 10.1007/s13205-025-04362-x. Epub 2025 Jun 9.
6
Biomaterials for bone infections: antibacterial mechanisms and immunomodulatory effects.用于骨感染的生物材料:抗菌机制与免疫调节作用
Front Cell Infect Microbiol. 2025 May 27;15:1589653. doi: 10.3389/fcimb.2025.1589653. eCollection 2025.
7
The Toxicological Profile of Active Pharmaceutical Ingredients-Containing Nanoparticles: Classification, Mechanistic Pathways, and Health Implications.含活性药物成分的纳米颗粒的毒理学概况:分类、作用机制途径及对健康的影响
Pharmaceuticals (Basel). 2025 May 9;18(5):703. doi: 10.3390/ph18050703.
8
A drug delivery perspective on nanotechnology-based topical therapeutics for inflammatory skin diseases.基于纳米技术的炎症性皮肤病局部治疗药物递送展望
Nanomedicine (Lond). 2025 Jun;20(12):1441-1459. doi: 10.1080/17435889.2025.2506347. Epub 2025 May 25.
9
Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection.用于治疗SARS-CoV-2感染的雾化载有甲磺酸卡莫司他的纳米脂质体的制剂及体外测试
AAPS PharmSciTech. 2025 May 16;26(5):139. doi: 10.1208/s12249-025-03099-3.
10
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment.对抗耐多药结核病的创新策略:药物递送系统与治疗的进展
Microorganisms. 2025 Mar 24;13(4):722. doi: 10.3390/microorganisms13040722.
Pharmaceuticals (Basel). 2021 Mar 26;14(4):296. doi: 10.3390/ph14040296.
4
Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis.《遗传性转甲状腺素蛋白淀粉样变性患者多神经病治疗药物帕替拉韦(ONPATTRO®)综述》勘误
Neurol Ther. 2021 Jun;10(1):407. doi: 10.1007/s40120-020-00228-x.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy.用于癌症治疗的聚(ADP-核糖)聚合酶抑制剂的纳米颗粒制剂
Front Chem. 2020 Nov 23;8:594619. doi: 10.3389/fchem.2020.594619. eCollection 2020.
7
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
8
Towards bio-compatible magnetic nanoparticles: Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance.迈向生物相容性磁性纳米颗粒:两性离子铁氧体纳米颗粒的免疫相关效应、体外内化及体内生物分布与意外的肾脏清除率
J Colloid Interface Sci. 2021 Jan 15;582(Pt B):678-700. doi: 10.1016/j.jcis.2020.08.026. Epub 2020 Aug 11.
9
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology.高分子纳米粒子:生产、表征、毒理学和生态毒理学。
Molecules. 2020 Aug 15;25(16):3731. doi: 10.3390/molecules25163731.
10
Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: Development, characterization, in-vitro studies.表面修饰丝素纳米粒提高多柔比星的递送:制备、表征、体外研究。
Int J Biol Macromol. 2020 Dec 1;164:2018-2027. doi: 10.1016/j.ijbiomac.2020.07.326. Epub 2020 Aug 3.